Investors

Press Releases

All Releases

View Summary EYLEA® (aflibercept) Injection Approved for the Treatment of Wet Age-Related Macular Degeneration in Japan
Sep 28, 2012
PDF 19.9 KB Add to Briefcase
View Summary Regeneron Announces FDA Approval of EYLEA® (aflibercept) Injection For Macular Edema Following Central Retinal Vein Occlusion
Sep 21, 2012
PDF 18.3 KB Add to Briefcase
View Summary Regeneron Named World's #1 Biopharmaceutical Employer in Science Magazine Annual Survey
Sep 21, 2012
PDF 10.8 KB Add to Briefcase
View Summary EYLEA® (aflibercept) Injection Recommended for Approval for the Treatment of Wet Age-Related Macular Degeneration in Europe
Sep 21, 2012
PDF 18.5 KB Add to Briefcase
View Summary Regeneron Announces September 2012 Investor Conference Presentations
Aug 29, 2012
PDF 9.7 KB Add to Briefcase
View Summary U.S. FDA Approves ZALTRAP® (ziv-aflibercept) After Priority Review for Previously Treated Metastatic Colorectal Cancer
Aug 3, 2012
PDF 76.6 KB Add to Briefcase
View Summary Regeneron Receives Complete Response Letter From FDA for ARCALYST® (rilonacept) sBLA for the Prevention of Gout Flares in Patients Initiating Uric Acid-lowering Therapies
Jul 30, 2012
PDF 13.4 KB Add to Briefcase
View Summary Regeneron Reports Second Quarter 2012 Financial and Operating Results
Jul 25, 2012
PDF 29.8 KB Add to Briefcase
View Summary Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody
Jul 20, 2012
PDF 22.2 KB Add to Briefcase
View Summary Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
Jul 11, 2012
PDF 9.5 KB Add to Briefcase
View Summary Regeneron Announces June 2012 Investor Conference Presentations
May 30, 2012
PDF 9.8 KB Add to Briefcase
View Summary Sanofi and Regeneron Announce Publication of Positive Phase 2 Results for Lipid-Lowering PCSK9 Antibody in The Lancet
May 26, 2012
PDF 22.0 KB Add to Briefcase
View Summary Regeneron Announces Presentation at the Bank of America Merrill Lynch 2012 Healthcare Conference
May 10, 2012
PDF 9.6 KB Add to Briefcase
View Summary Regeneron Announces Participation in J. P. Morgan Biotech: CEO/CFO Conference Call Series
May 9, 2012
PDF 9.4 KB Add to Briefcase
View Summary Regeneron Provides Update On FDA Advisory Committee Discussion of ARCALYST® (rilonacept) Injection
May 8, 2012
PDF 13.2 KB Add to Briefcase
View Summary Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
May 8, 2012
PDF 111.6 KB Add to Briefcase
View Summary Regeneron Reports First Quarter 2012 Financial and Operating Results
Apr 26, 2012
PDF 28.3 KB Add to Briefcase
View Summary Regeneron to Report First Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on April 26, 2012
Apr 12, 2012
PDF 9.3 KB Add to Briefcase
View Summary Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP® (aflibercept)
Apr 5, 2012
PDF 18.2 KB Add to Briefcase
View Summary Sanofi and Regeneron Report Phase 2 Data for Potential First-in-Class Lipid-Lowering PCSK9 Antibody
Mar 26, 2012
PDF 21.9 KB Add to Briefcase
Showing 101-120 of 244 Page: 1 2 3 4 5 6 7 8 9 10 ... 13  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase


Close
Form content here please :)